ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.09
+0.47 (2.17%)
At close: Jun 22, 2026, 4:00 PM EDT
22.50
+0.41 (1.86%)
After-hours: Jun 22, 2026, 4:20 PM EDT
ACADIA Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, ACADIA Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $31.65. The average 1-year stock price forecast is 43.28% higher than the current stock price, while the lowest is $17 (-23.04%) and the highest is $45 (+103.71%).
Price Target: $31.65 (+43.28%)
Analyst Consensus: Buy
* Price targets were last updated on May 22, 2026.
Analyst Ratings
The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 11 | 12 | 12 | 12 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 6 | 6 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 20 | 20 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold Maintains $23 | Hold | Maintains | $23 | +4.12% | May 22, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $34 | Buy | Maintains | $34 | +53.92% | May 11, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 8, 2026 |
| Citi | Citi | Buy Maintains $33 → $32 | Buy | Maintains | $33 → $32 | +44.86% | May 8, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
Financial Forecast
Revenue This Year
1.24B
from 1.07B
Increased by 15.83%
Revenue Next Year
1.39B
from 1.24B
Increased by 11.88%
EPS This Year
0.40
from 0.83
Decreased by -52.13%
EPS Next Year
0.89
from 0.40
Increased by 124.80%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.3B | ||
| Avg | 1.2B | ||
| Low | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.9% | ||
| Avg | 15.8% | ||
| Low | 14.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.40 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -52.1% | ||
| Low | - |